Jaguar, Sean Nolan's latest biotech, raises $139M as they follow Taysha's footsteps
Joe Nolan swears he isn’t trying to hurtle Jaguar Gene Therapy toward a 0-to-60 IPO, but it sure looks like it.
Less than two months after launching with Deerfield cash and ex-AveXis leadership, Jaguar announced Tuesday they raised a $139 million Series B led by Eli Lilly and Deerfield. That rapid acceleration is reminiscent of the last biotech launched by the old AveXis team, when Sean Nolan and RA Sessions steered Taysha through back-to-back Series A and B rounds before landing a $157 million IPO last September, 5 months after launch.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.